A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: A pilot study

Journal of Electrocardiology

Volumn 45, Issue 2, 2012, Pages 109-115

  Vincenti, Antonio ^a   Rota, Matteo ^b   Spinelli, Monica ^a   Corciulo, Mariella ^a   De Ceglia, Sergio ^a   Rovaris, Giovanni ^a   Antolini, Laura ^b   Genovesi, Simonetta ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Atrial diameter; Atrial remodeling; Paroxysmal atrial fibrillation; Persistent atrial fibrillation; Remodeling index; Signal averaged P wave duration

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTICOAGULANT THERAPY; CARDIOVASCULAR PARAMETERS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIAL ANTEROPOSTERIOR DIAMETER; HUMAN; MAJOR CLINICAL STUDY; MALE; NONINVASIVE ATRIAL REMODELING INDEX; P WAVE; PAROXYSMAL ATRIAL FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; PRIORITY JOURNAL;

ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY;

EID: 84857108677     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2011.08.005     Document Type: Conference Paper

References (21)

1. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study Heart 86 2001 516
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370
3. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369
4. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230
5. S. Nattel, B. Burstein, and D. Dobrev Atrial remodeling and atrial fibrillation: mechanisms and implications Circ Arrhythm Electrophysiol 1 2008 62
6. P. Stafford, P. Denbigh, and R. Vincent Frequency analysis of the P wave: comparative techniques Pacing Clin Electrophysiol 18 1995 261
7. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440
8. R. Mazumdar, and J.R. Glassman Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments Stat Med 19 2000 113
9. R. Miller, and D. Siegmund Maximally selected chi square statistics Biometrics 38 1982 1011
10. D.W. Hosmer, and S. Lemeshow Applied logistic regression 1989 John Wiley & Sons Inc New York
11. F. Santoni-Rugiu, R. Verma, and D. Mehta Signal-averaged P-wave ECG discriminates between persistent and paroxysmal atrial fibrillation J Electrocardiol 34 2001 189
12. Y. Koide, M. Yotsukura, K. Sakata, H. Yoshino, and K. Ishikawa Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation Clin Cardiol 25 2002 69
13. C.B. de Vos, R. Pisters, and R. Nieuwlaat Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis J Am Coll Cardiol 55 2010 725
14. R. Cappato, H. Calkins, and S.A. Chen Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circulation 111 2005 1100
15. J.D. Fisher, M.A. Spinelli, D. Mookherjee, A.K. Krumerman, and E.C. Palma Atrial fibrillation ablation: reaching the mainstream Pacing Clin Electrophysiol 29 2006 523
16. A.N. Shah, S. Mittal, and T.C. Sichrovsky Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence J Cardiovasc Electrophysiol 19 2008 661
17. M. Haïssaguerre, M. Hocini, and P. Sanders Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias J Cardiovasc Electrophysiol 16 2005 1138
18. M.P. Schneider, T.A. Hua, M. Böhm, K. Wachtell, S.E. Kjeldsen, and R.E. Schmieder Prevention of atrial fibrillation by renin-angiotensin system inhibition: a meta-analysis J Am Coll Cardiol 55 2010 2299
19. M.B. Jibrini, J. Molnar, and R.R. Arora Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis Am J Ther 15 2008 36
20. GISSI-AF Investigators, M. Disertori, and R. Latini Valsartan for prevention of recurrent atrial fibrillation N Engl J Med 360 2009 1606
21. P. Alboni, G.L. Botto, and N. Baldi Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach N Engl J Med 351 2004 2384